Drug Shortage Report for CLAVULIN 125 F ORAL SUS
| Report ID | 171718 |
| Drug Identification Number | 01916882 |
| Brand name | CLAVULIN 125 F ORAL SUS |
| Common or Proper name | amoxicillin / clavulanate potassium for oral suspension |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | AMOXICILLIN CLAVULANIC ACID |
| Strength(s) | 125MG 31.25MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100ML |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-10-14 |
| Estimated end date | 2023-07-07 |
| Actual end date | 2023-06-20 |
| Shortage status | Resolved |
| Updated date | 2024-02-14 |
| Company comments | For emergency supply, contact GSK Customer Service 1-800-387-7374. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-10-14 | English | Compare |